IL216148A0 - Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide - Google Patents

Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide

Info

Publication number
IL216148A0
IL216148A0 IL216148A IL21614811A IL216148A0 IL 216148 A0 IL216148 A0 IL 216148A0 IL 216148 A IL216148 A IL 216148A IL 21614811 A IL21614811 A IL 21614811A IL 216148 A0 IL216148 A0 IL 216148A0
Authority
IL
Israel
Prior art keywords
dimethyl
butyramide
morpholin
phenyl
stable forms
Prior art date
Application number
IL216148A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL216148(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL216148A0 publication Critical patent/IL216148A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL216148A 2009-05-11 2011-11-03 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide IL216148A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11
PCT/DK2010/050101 WO2010130260A2 (en) 2009-05-11 2010-05-11 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide

Publications (1)

Publication Number Publication Date
IL216148A0 true IL216148A0 (en) 2012-01-31

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
IL216148A IL216148A0 (en) 2009-05-11 2011-11-03 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide

Country Status (23)

Country Link
EP (1) EP2430008A2 (de)
JP (1) JP2012526152A (de)
KR (1) KR20120022934A (de)
CN (1) CN102459208A (de)
AR (1) AR076556A1 (de)
AU (1) AU2010246724B2 (de)
BR (1) BRPI1013930A2 (de)
CA (1) CA2761383A1 (de)
CL (1) CL2011002814A1 (de)
CO (1) CO6460741A2 (de)
CR (1) CR20110590A (de)
DO (1) DOP2011000351A (de)
EA (1) EA201171381A1 (de)
GE (1) GEP20146006B (de)
IL (1) IL216148A0 (de)
MA (1) MA33351B1 (de)
MX (1) MX2011011885A (de)
NZ (1) NZ596738A (de)
SG (1) SG175968A1 (de)
TN (1) TN2011000557A1 (de)
TW (1) TW201041857A (de)
WO (1) WO2010130260A2 (de)
ZA (1) ZA201108112B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119490430A (zh) 2019-08-02 2025-02-21 H.隆德贝克有限公司 用于在癫痫或癫痫发作中使用的作为Kv7钾通道开放剂的醇衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
BRPI0716715B1 (pt) * 2006-08-23 2021-07-06 Xenon Pharmaceuticals, Inc Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula
EP2185149A1 (de) * 2007-08-01 2010-05-19 H. Lundbeck A/S Verwendung von kncq-kaliumkanal-öffnern zur verringerung von symptomen oder zur behandlung von erkrankungen oder störungen mit unterbrechung des dopaminergen systems

Also Published As

Publication number Publication date
SG175968A1 (en) 2011-12-29
MA33351B1 (fr) 2012-06-01
TW201041857A (en) 2010-12-01
BRPI1013930A2 (pt) 2019-09-24
CA2761383A1 (en) 2010-11-18
NZ596738A (en) 2013-04-26
CN102459208A (zh) 2012-05-16
EP2430008A2 (de) 2012-03-21
WO2010130260A2 (en) 2010-11-18
JP2012526152A (ja) 2012-10-25
MX2011011885A (es) 2011-12-06
TN2011000557A1 (en) 2013-05-24
CO6460741A2 (es) 2012-06-15
AR076556A1 (es) 2011-06-22
KR20120022934A (ko) 2012-03-12
CL2011002814A1 (es) 2012-04-13
WO2010130260A3 (en) 2011-06-16
GEP20146006B (en) 2014-01-10
AU2010246724A1 (en) 2011-12-08
EA201171381A1 (ru) 2012-05-30
CR20110590A (es) 2012-02-22
WO2010130260A9 (en) 2012-10-18
ZA201108112B (en) 2013-01-30
DOP2011000351A (es) 2012-01-31
AU2010246724B2 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
PL2719699T3 (pl) Pewne triazolopirazyny, ich kompozycje i sposoby ich stosowania
SG10201401415QA (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
GB0914644D0 (en) Novel agents and uses thereof
SI2398785T1 (sl) Äśiĺ äśenje 1-(2-(2,4-dimetilfenilsulfanil)fenil)-piperazina
GB0917044D0 (en) Agents, uses and methods
EP2427995A4 (de) Proaktive authentifizierung
GB0917054D0 (en) Agents, uses and methods
ZA201203137B (en) Substituted benzamide derivatives
IL217183A0 (en) Benzamide derivatives
PL2470499T3 (pl) Nowe pochodne kolchicyny, sposoby i ich zastosowania
IL215153A0 (en) Amide derivative compounds, compositions comprising the same and uses there of
EP2518069A4 (de) Zyklische aminverbindung und akarizid
EP2405149A4 (de) Klemme
IL216462A0 (en) Nitrile derivatives, compositions comprising the same and uses thereof
IL217928A0 (en) Amide derivatives, compositions comprising the same and uses thereof
EP2444330A4 (de) Klemme
ZA201108112B (en) Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
GB2473461B (en) Clip
GB2471332B (en) Clip
PL2429334T3 (pl) Klamerka do paska od smoczka
GB0918167D0 (en) Clip
SI2325412T1 (sl) Sponka, prednostno iz kovine
AP2012006129A0 (en) Benzamide derivatives, preparation and use thereof.
EP2509457A4 (de) Klammer für ein kleidungsstück
TWM365753U (en) Vibration-massaging ear clip